Golimumab Preserves Insulin Production in Type 1 Diabetes Golimumab Preserves Insulin Production in Type 1 Diabetes

For newly diagnosed patients, injections of the monoclonal antibody every 2 weeks preserved C-peptide levels and reduced required insulin doses at 1 year.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news